Lisa Horvath

Professor Lisa Horvath is a Medical Oncologist and faculty member at the Central Clinical School, University of Sydney. Her research focuses on prostate cancer with emphasis on lipid metabolism, biomarker discovery, and chemotherapy resistance.

Research Interests:

• Lipidomic profiling in advanced prostate cancer
• Androgen receptor signaling pathways
• Germline genetic testing applications
• Neurotoxicity in cancer survivors

Scientific Contributions: She has authored numerous high-impact publications on topics ranging from circulating lipid biomarkers to novel imaging agents in metastatic prostate cancer. Her work includes clinical trial protocols and cost-effectiveness analyses for precision oncology approaches.

Current Role: Leads research on metabolic reprogramming in prostate cancer, collaborates with multidisciplinary teams on biomarker validation, and contributes to clinical guidelines development.